1. Home
  2. CRBU vs SRI Comparison

CRBU vs SRI Comparison

Compare CRBU & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • SRI
  • Stock Information
  • Founded
  • CRBU 2011
  • SRI 1965
  • Country
  • CRBU United States
  • SRI United States
  • Employees
  • CRBU N/A
  • SRI N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • SRI Auto Parts:O.E.M.
  • Sector
  • CRBU Health Care
  • SRI Consumer Discretionary
  • Exchange
  • CRBU Nasdaq
  • SRI Nasdaq
  • Market Cap
  • CRBU 179.7M
  • SRI 210.9M
  • IPO Year
  • CRBU 2021
  • SRI 1997
  • Fundamental
  • Price
  • CRBU $2.32
  • SRI $6.77
  • Analyst Decision
  • CRBU Strong Buy
  • SRI Buy
  • Analyst Count
  • CRBU 3
  • SRI 1
  • Target Price
  • CRBU $6.67
  • SRI $16.00
  • AVG Volume (30 Days)
  • CRBU 1.1M
  • SRI 173.6K
  • Earning Date
  • CRBU 11-07-2025
  • SRI 11-05-2025
  • Dividend Yield
  • CRBU N/A
  • SRI N/A
  • EPS Growth
  • CRBU N/A
  • SRI N/A
  • EPS
  • CRBU N/A
  • SRI N/A
  • Revenue
  • CRBU $9,121,000.00
  • SRI $877,921,000.00
  • Revenue This Year
  • CRBU $8.06
  • SRI N/A
  • Revenue Next Year
  • CRBU N/A
  • SRI $7.68
  • P/E Ratio
  • CRBU N/A
  • SRI N/A
  • Revenue Growth
  • CRBU N/A
  • SRI N/A
  • 52 Week Low
  • CRBU $0.66
  • SRI $3.54
  • 52 Week High
  • CRBU $3.00
  • SRI $9.66
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 47.97
  • SRI 46.21
  • Support Level
  • CRBU $2.35
  • SRI $7.00
  • Resistance Level
  • CRBU $2.59
  • SRI $7.49
  • Average True Range (ATR)
  • CRBU 0.21
  • SRI 0.36
  • MACD
  • CRBU -0.06
  • SRI 0.07
  • Stochastic Oscillator
  • CRBU 11.43
  • SRI 63.57

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

Share on Social Networks: